SCHEMBL5686135

SCHEMBL5686135

CCOC(=O)c1ccc(NC(C)=O)c(CN(CC)CC)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.58
POLB P06746 3/20 0.48
SMN1; SMN2 Q16637 7/20 0.47
NPC1 O15118 6/20 0.47
RAB9A P51151 6/20 0.47
ALDH1A1 P00352 4/20 0.47
STAT1 P42224 1/20 0.47
KDM4E B2RXH2 1/20 0.47
TP53 P04637 2/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
MEP1B Q16820 1/20 0.45
MAPT P10636 4/20 0.45
LMNA P02545 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11617717 0.90 KMT2A (0.51) KMT2APOLBSMN1; SMN2NPC1RAB9A
SCHEMBL11622464 0.89 ALDH1A1 (0.54) KMT2APOLBSMN1; SMN2ALDH1A1KDM4E
SCHEMBL5682853 0.86 KMT2A (0.61) KMT2APOLBSMN1; SMN2NPC1RAB9A
SCHEMBL11619511 0.85 POLB (0.66) KMT2APOLBSMN1; SMN2ALDH1A1TP53
SCHEMBL11617100 0.85 ALDH1A1 (0.48) KMT2APOLBSMN1; SMN2NPC1RAB9A
SCHEMBL8887650 0.83 KMT2A (0.57) KMT2APOLBSMN1; SMN2NPC1RAB9A
SCHEMBL5683316 0.81 CYP1A2 (0.53) POLBALDH1A1CA12CA1CA2
SCHEMBL11620804 0.81 ALOX15 (0.50) KMT2APOLBSMN1; SMN2NPC1RAB9A
SCHEMBL11619395 0.80 MAPT (0.50) KMT2APOLBSMN1; SMN2NPC1RAB9A
SCHEMBL5682954 0.80 KMT2A (0.67) KMT2APOLBSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1645556-A1 Arylpiperazine-benzoylamide derivatives useful as pharmaceutical agents Boehringer Ingelheim International GmbH (DE) 2006-04-12 EP disclosed
US-RE29628-E ANTIULCER, SECRETOLYTICS, ANTITUSSIVE BOEHRINGER INGELHEIM GMBH (DT) 1978-05-09 US disclosed
US-4006246-A ANTIULCER, SECRETOLYTIC, ANTITUSSIVE, STIMULANT BOEHRINGER INGELHEIM GMBH (DT) 1977-02-01 US disclosed
US-3950393-A ANTIULCER, ANTISECRETORY, ANTITUSSIVE AGENTS BOEHRINGER INGELHEIM GMBH (DT) 1976-04-13 US disclosed